Search Results - "Fang, Shuogui"

Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis by Huang, Yi, Chen, Zhijian, Shen, Gang, Fang, Shuogui, Zheng, Junjiong, Chi, Zepai, Zhang, Yuanfeng, Zou, Yitong, Gan, Qinghua, Liao, Chengxiao, Yao, Yuhui, Kong, Jianqiu, Fan, Xinxiang

“…This study aims to conduct a bibliometric analysis, employing visualization tools to examine literature pertaining to tumor immune evasion related to…”
Get full text

Assessing the predictive value of smoking history for immunotherapy outcomes in bladder cancer patients by Kong, Jianqiu, Zou, Yitong, Zhou, Hua, Huang, Yi, Lin, Ying, Fang, Shuogui, Chen, Zhijian, Zheng, Junjiong, Huang, Yaqiang, Shen, Zefeng, Xie, Weibin, Fan, Xinxiang

“…The therapeutic effectiveness of immune checkpoint inhibitors (ICIs) in bladder cancer varies among individuals. Identifying reliable predictors of response to…”
Get full text

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising? by Fang, Shuogui, Zhong, Jian, Mai, Zihang, Li, Tong, Xie, Xiuying, Fu, Jianhua

“…Background The role of adjuvant chemotherapy in patients with pathological lymph node‐positive (pN+) resectable esophageal squamous cell carcinoma (ESCC)…”
Get full text

Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer by Mai, Zihang, Yuan, Jianye, Yang, Hong, Fang, Shuogui, Xie, Xiuying, Wang, Xinye, Xie, Jiaxin, Wen, Jing, Fu, Jianhua

“…Identification of molecular subtypes that reflect different prognoses and treatment responses, especially immune checkpoint inhibitors (ICIs) in esophageal…”
Get full text

Prognostic impact of sterilized lymph nodes in esophageal squamous cell carcinomas after neoadjuvant chemoradiotherapy by Zhong, Jian, Wang, Kexi, Fang, Shuogui, Fu, Jianhua

“…The prognostic importance of sterilized lymph nodes (SLN) remains unclear in patients with esophageal squamous cell carcinomas (ESCC) treated by neoadjuvant…”
Get full text

The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy by Zhong, Jian, Fang, Shuogui, Chen, Rui, Yuan, Jianye, Xie, Xiuying, Lin, Ting, Liu, Mengzhong, Liu, Qianwen, Fu, Jianhua

“…The goal of this study was to investigate the patterns and risk factors for recurrence in patients with oesophageal squamous cell carcinoma with a pathological…”
Get full text

183. IMPACTS OF NEOADJUVANT CHEMORADIOTHERAPY ON THE IMMUNE LANDSCAPE OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA by Wen, Jing, Fang, Shuogui, Hu, Yi, Xi, Mian, Weng, Zelin, Fu, Jianhua, Yang, Hong

“…Abstract Neoadjuvant chemoradiation (neoCRT) followed by surgery is the most common approach for locally advanced resectable esophageal squamous cell carcinoma…”
Get full text

289. RISK FACTOR OF RELAPSE IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA WHO ACHIEVE PATHOLOGIC COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY by Zhong, Jian, Fang, Shuogui, Yuan, Jianye, Chen, Rui, Xie, Xiuying, Lin, Ting, Liu, Mengzhong, Liu, Qianwen, Fu, Jianhua

“…Abstract Background Controversy still exists as to the risk factors of recurrence in patients with esophageal squamous cell carcinoma (ESCC) who achieve…”
Get full text

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma by Wen, Jing, Fang, Shuogui, Hu, Yi, Xi, Mian, Weng, Zelin, Pan, Chuqing, Luo, Kongjia, Ling, Yihong, Lai, Renchun, Xie, Xiuying, Lin, Xiaodan, Lin, Ting, Chen, Jiyang, Liu, Qianwen, Fu, Jianhua, Yang, Hong

“…Neoadjuvant chemoradiotherapy (neoCRT) followed by surgery is the most common approach for locally advanced resectable esophageal squamous cell carcinoma…”
Get full text

Integration of Tumor Heterogeneity for Recurrence Prediction in Patients with Esophageal Squamous Cell Cancer by Mai, Zihang, Liu, Qianwen, Wang, Xinye, Xie, Jiaxin, Yuan, Jianye, Zhong, Jian, Fang, Shuogui, Xie, Xiuying, Yang, Hong, Wen, Jing, Fu, Jianhua

“…Esophageal squamous cell carcinoma (ESCC) is one of the deadliest malignancies in China. The prognostic value of mutations, especially those in minor tumor…”
Get full text

Development and Validation of Survival Nomograms in Patients with Primary Bladder Lymphoma by Lin, Junyi, Kong, Jianbin, Luo, Mingli, Shen, Zefeng, Fang, Shuogui, Hu, Jintao, Xu, Zixin, Dong, Wen, Huang, Jian, Lin, Tianxin

“…The existing studies on primary bladder lymphoma (PBL) are retrospective analyses based on individual cases or small series studies, and the research on PBL is…”
Get full text

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinomaResearch in context by Jing Wen, Shuogui Fang, Yi Hu, Mian Xi, Zelin Weng, Chuqing Pan, Kongjia Luo, Yihong Ling, Renchun Lai, Xiuying Xie, Xiaodan Lin, Ting Lin, Jiyang Chen, Qianwen Liu, Jianhua Fu, Hong Yang

“…Background: Neoadjuvant chemoradiotherapy (neoCRT) followed by surgery is the most common approach for locally advanced resectable esophageal squamous cell…”
Get full text